← All organizations
Highest phase reached
Phase 4
First clinical trial
Jul 1, 2007Last known activity
Sep 30, 2024
Timeline
No events for the selected filters.
Drugs by trial phase (19 distinct, 5 trials)
Phase 4 (7 own, 0 via acquisition)
Phase 3 (10 own, 0 via acquisition)
Phase 1 (2 own, 0 via acquisition)
Indications
Studied for
Recent trials (7)
- NCT06436274CollaboratorPhase 4Sep 30, 2024
- NCT04767217CollaboratorPhase 4Jun 14, 2021
- NCT02391077Overall official - principal investigatorPhase 1Apr 30, 2015
- NCT02391077Reponsible party - principal investigatorPhase 1Apr 30, 2015
- NCT02391077Lead sponsorPhase 1Apr 30, 2015
- NCT01127204CollaboratorPhase 2/Phase 3Jun 1, 2011
- NCT00393679CollaboratorPhase 3Jul 1, 2007
Details
- Last known activity
- Sep 30, 2024